1. 1. Libby P, Nahrendorf M, Swirski FK. Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded "cardiovascular continuum" . J Am Coll Cardiol 67: 1091-1103, 2016.
2. 2. de Souza Bastos A, Graves DT, de Melo Loureiro AP, et al. Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. J Diabetes Complications 30: 1593-1599, 2016.
3. 3. Herder C, Færch K, Carstensen-Kirberg M, et al. Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study. Eur J Endocrinol 175: 367-377, 2016.
4. 4. Joshi AA, Lerman JB, Aberra TM, et al. GlycA is a novel biomarker of inflammation and subclinical cardiovascular disease in psoriasis. Circ Res pii: CIRCRESAHA.116.309637, 2016.
5. 5. Boehncke WH, Schön MP. Psoriasis. Lancet 386: 983-994, 2015.